A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic
Justin Baroukhian, Kristina Seiffert-Sinha, Animesh A. Sinha · 2025
Read A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic by Justin Baroukhian, Kristina Seiffert-Sinha, Animesh A. Sinha (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11790476.txt.
Description
Justin Baroukhian, Kristina Seiffert-Sinha, and Animesh Sinha tested old claims that certain drugs trigger pemphigus, using population data, in a 2024 study. Pemphigus is a blistering autoimmune disease where the skin's glue fails. Case reports have blamed many drugs over the years, but anecdotes cannot separate cause from coincidence.
The team ran case-control analyses on the federal adverse event database across the full list of reported trigger drugs. One shared trait stood out among the drugs that held up: the capacity to modulate the immune system. That pattern supports a real mechanism rather than random blame. The work helps doctors judge which drug histories matter when a new pemphigus case appears.
Catalog record
| CREATOR | Justin Baroukhian, Kristina Seiffert-Sinha, Animesh A. Sinha |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |